SpringerLink
Log in

Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objectives of the study were to evaluate the prevalence of antinuclear antibodies (ANA) in patients with fibromyalgia (FM) and the probability of the development of clinically overt connective tissue diseases. Four hundred and fifty FM patients were compared to 129 healthy matched blood donors. ANA testing was performed by immunofluorescence on rat tissue sections; in case of highly positive results, ANA were specified further by ELISA and immunodiffusion. All ANA positive FM patients were invited for a control examination. The ANA negative patients received a questionnaire, which was designed to identify those patients with possible connective tissue diseases (CTD). There was no significant difference in the frequency of ANA or thyroid antibodies between patients and controls (11.6% vs. 7%). Two patients had developed SLE: one was already ANA/anti-dsDNA positive at time of first diagnosis of FM; in the other, specific antibodies and SLE-related symptoms developed after 4.5 years. The probability for FM patients to develop CTD (SLE) within one year is 0.0027%, which is comparable to the incidence of SLE in the general population (0.005%). The risk of CTD is not increased in FM. The detection of ANA does not predict the development of CTD. However, in individual cases, FM may be an early sign of an autoimmune disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. 1990 classification criteria of fibromyalgia from the American College of Rheumatology. Report of the multicenter criteria committee. Union Med Can 1990 119:272

    Google Scholar 

  2. Wallace DJ (1997) The fibromyalgia syndrome. Ann Med 29:9–21

    PubMed  CAS  Google Scholar 

  3. Goldenberg DL (1999) Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med 159:777–785

    Article  PubMed  CAS  Google Scholar 

  4. Ledingham J, Doherty S, Doherty M (1993) Primary fibromyalgia syndrome–an outcome study. Br J Rheumatol 32:139–42

    Article  PubMed  CAS  Google Scholar 

  5. Russell AS, Percy JS (1994) Disabling fibromyalgia: appearance vs reality. J Rheumatol 21:1580

    PubMed  CAS  Google Scholar 

  6. White KP, Harth M, Teasell RW (1995) Work disability evaluation and the fibromyalgia syndrome. Semin Arthritis Rheum 24:371–381

    Article  PubMed  CAS  Google Scholar 

  7. Wolfe F, Aarflot T, Bruusgaard D, et al (1995) Fibromyalgia and disability. Report of the Moss international working group on medico-legal aspects of chronic widespread musculoskeletal pain complaints and fibromyalgia. Scand J Rheumatol 24:112–118

    PubMed  CAS  Google Scholar 

  8. Bennett RM (1996) Fibromyalgia and the disability dilemma. A new era in understanding a complex, multidimensional pain syndrome. Arthritis Rheum 39:1627–1634

    Article  PubMed  CAS  Google Scholar 

  9. Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W (1996) Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 101:364–70

    Article  PubMed  CAS  Google Scholar 

  10. Wolfe F, Potter J (1996) Fibromyalgia and work disability: is Fibromyalgia a disabling disorder? Rheum Dis Clin North Am 22:369–391

    Article  PubMed  CAS  Google Scholar 

  11. Noller V, Sprott H (2003) Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J Negat Results Biomed 2:4

    Article  PubMed  Google Scholar 

  12. Hudson JI, Pope HG (1994) The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol 8:839–856

    Article  PubMed  CAS  Google Scholar 

  13. Dohrenbusch R, Gruterich M, Genth E (1996) Fibromyalgia and Sjogren syndrome–clinical and methodological aspects. Z Rheumatol 55:19–27

    PubMed  CAS  Google Scholar 

  14. Tishler M, Barak Y, Paran D, Yaron M (1997) Sleep disturbances, fibromyalgia and primary Sjogren’s syndrome. Clin Exp Rheumatol 15:71–74

    PubMed  CAS  Google Scholar 

  15. Morand EF, Miller MH, Whittingham S, Littlejohn GO (1994) Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus 3:187–191

    PubMed  CAS  Google Scholar 

  16. Middleton GD, McFarlin JE, Lipsky PE (1994) The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37:1181–1188

    Article  PubMed  CAS  Google Scholar 

  17. Al-Allaf AW, Ottewell L, Pullar T (2002) The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2–4 years’ follow-up. Clin Rheumatol 21:472–477

    Article  PubMed  CAS  Google Scholar 

  18. Dinerman H, Goldenberg DL, Felson DT (1986) A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud’s phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 13:368–373

    PubMed  CAS  Google Scholar 

  19. Bridges AJ (1993) Fibromyalgia, antinuclear antibodies and clinical features of connective tissue disease. Clin Exp Rheumatol 11:696–697

    PubMed  CAS  Google Scholar 

  20. McLain DA (1998) Clinical features of ANA-positive and ANA-negative patients with fibromyalgia. J Clin Rheumatol 4:292–293

    Article  PubMed  CAS  Google Scholar 

  21. Calvo-Alen J, Bastian HM, Straaton KV, Burgard SL, Mikhail IS, Alarcon GS (1995) Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum 38:1475–1484

    Article  PubMed  CAS  Google Scholar 

  22. Ritts RE, Mackay IR (1979) WHO handbook of immunological tecjniques: World Health Organisation

  23. Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen preparation with sera of patients with systemic lupus erythematosus. J Immunol 96:464

    PubMed  CAS  Google Scholar 

  24. Tan EM, Cohen H, Fries JF et al (1982) The 1982 Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  PubMed  CAS  Google Scholar 

  25. Yunus MB, Hussey FX, Aldag JC (1993) Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. J Rheumatol 20:1557–1560

    PubMed  CAS  Google Scholar 

  26. Bengtsson A, Ernerudh J, Vrethem M, Skogh T (1990) Absence of autoantibodies in primary fibromyalgia. J Rheumatol 17:1682–1683

    PubMed  CAS  Google Scholar 

  27. Silverman S, Gluck O, Silver D et al (1996) The prevalence of autoantibodies in symptomatic and asymptomatic patients with breast implants and patients with fibromyalgia. Curr Top Microbiol Immunol 210:317–322

    PubMed  CAS  Google Scholar 

  28. Bridges AJ, Anderson JD, Burns DE, Kemple K, Kaplan JD, Lorden T (1996) Autoantibodies in patients with silicone implants. Curr Top Microbiol Immunol 210:277–282

    PubMed  CAS  Google Scholar 

  29. Klein R, Berg PA (1994) A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome. Clin Investig 72:541–549

    Article  PubMed  CAS  Google Scholar 

  30. Forslid J, Heigl Z, Jonsson J, Scheynius A (1994) The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with Hep-2 cells as antigen substrate. Clin Exp Rheumatol 12:137–141

    PubMed  CAS  Google Scholar 

  31. Petri M, Karlson EW, Cooper DS, Ladenson PW (1991) Autoantibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol 18:1529–1531

    PubMed  CAS  Google Scholar 

  32. Mutasim DF, Adams BB (2000) A practical guide for serologic evaluation of autoimmune connective tissue diseases. J Am Acad Dermatol 42:159–174

    Article  PubMed  CAS  Google Scholar 

  33. Kavanaugh AF, Tomar R, Reveille JD, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 124:71–81

    PubMed  CAS  Google Scholar 

  34. Hayashi N, Kawamoto T, Mukai M et al (2001) Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear Hep-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem 47:1649–1659

    PubMed  CAS  Google Scholar 

  35. Pandey JP, Fudenberg HH, Ainsworth SK, Loadholt CB (1979) Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev 10:399–404

    Article  PubMed  CAS  Google Scholar 

  36. Tan EM, Feltkamp TE, Smolen J, Butcher B, Dawkins R, Fritzler MJ (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40:1601–1611

    Article  PubMed  CAS  Google Scholar 

  37. Vaile JH, Dyke L, Kherani R, Johnston C, Higgins T, Russell AS (2000) Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 18:433–438

    PubMed  CAS  Google Scholar 

  38. De Vlam K, De Keyser F, Verbruggen G, et al (1993) Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 11:393–397

    PubMed  Google Scholar 

  39. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ (1985) Antinuclear, anticytoplasmatic, and anti-Sjogren’s syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 36(1):120–128

    Article  PubMed  CAS  Google Scholar 

  40. Craig WY, Ledue TB, Johnson AM, Ritchie RF (1999) The distribution of antinuclear antibody titres in “normal” children and adults. J Rheumatol 26:914–919

    PubMed  CAS  Google Scholar 

  41. Moulias R, Proust J, Wang A et al (1984) Age-related increase in autoantibodies. Lancet 1:1128–1129

    Article  PubMed  CAS  Google Scholar 

  42. Vrethem M, Skogh T, Berlin G, Ernerudh J (1992) Autoantibodies versus clinical symptoms in blood donors. J Rheumatol 19:1919–1921

    PubMed  CAS  Google Scholar 

  43. Bastian HM, Amos M, Mikhail IS (1996) Serological characterisation of patients with ANA-positive fibromyalgia-manifestations using autoantibody ELISA. Arthritis Rheum 39:S274

    Google Scholar 

  44. Walz Le Blanc BAE, Gladman DD, Urowitz MB (1994) Serologically active clinically quiescent systemic lupus erythematosus: predictors of clinical flares. J Rheumatol 21:2239–2241

    CAS  Google Scholar 

  45. Petri M (1995) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 7:395–401

    Article  PubMed  CAS  Google Scholar 

  46. Aho K, Koskela P, Mäkitalo R, Heliovaara M, Palosuo T (1992) Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 19:1377–1379

    PubMed  CAS  Google Scholar 

  47. Smart PA, Waylonis GW, Hackshaw KV (1997) Immunologic profile of patients with fibromyalgia. Am J Phys Med Rehabil 76:231–234

    Article  PubMed  CAS  Google Scholar 

  48. Dijkstra S, Nieuwenhuis EJ, Swaak AJG (1999) The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterised by the presence of antinuclear antibodies (ANA). Scand J Rheumatol 28:33–37

    Article  PubMed  CAS  Google Scholar 

  49. Arbuckle M, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the cllinical onset of systemic lupus erythematosus. N Engl J Med 349:1526–1533

    Article  PubMed  CAS  Google Scholar 

  50. Vlachoyiannopoulos PG, Tzayara V, Dafni U, Spanos E, Moutsopoulos HM (1998) Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. J Rheumatol 25:886–891

    PubMed  CAS  Google Scholar 

  51. Deane PM, Liard G, Siegel DM, Baum J (1995) The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 95:892–895

    PubMed  CAS  Google Scholar 

  52. Myckatyn SO, Russell AS (2003) Outcome of positive antinuclear antibodies in individuals without connective tissue disease. J Rheumatol 30:736–739

    PubMed  Google Scholar 

  53. Swaak AJG, Smeenk RJ (1985) Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 44:245–251

    Article  PubMed  CAS  Google Scholar 

  54. Yadin O, Sarov B, Naggan L, Slor H, Shoenfeld Y (1989) Natural autoantibodies in the serum of healthy women––a five year follow-up. Clin Exp Immunol 75:402–406

    PubMed  CAS  Google Scholar 

  55. Bengtsson A, Backman E, Lindblom B, Skogh T (1994) Long term follow-up of fibromyalgia patients: clinical symptoms, muscular function, laboratory tests––an eight year comparison study. J Musculoskelet Pain 2:67–80

    Article  Google Scholar 

  56. Bonafede RP, Downey DC, Bennett RM (1995) An association of fibromyalgia with primary Sjogren’s syndrome: a prospective study of 72 patients. J Rheumatol 22:133–136

    PubMed  CAS  Google Scholar 

  57. Gran JT (2002) Diagnosis and definition of primary Sjogren’s syndrome. Scand J Rheumatol 31:57–59

    Article  PubMed  Google Scholar 

  58. Vivino FB, Gala I, Hermann GA (2002) Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 29:938–944

    PubMed  Google Scholar 

  59. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–556

    Article  PubMed  CAS  Google Scholar 

  60. Buskila D, Press J, Abu-Shakra M (2003) Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 25:25–28

    Article  PubMed  Google Scholar 

  61. Aaron LA, Buchwald D (2001) A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134:868–881

    PubMed  CAS  Google Scholar 

  62. Wolfe F (1999) Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 38:355–361

    Article  CAS  Google Scholar 

  63. Wolfe F, Hawley DJ, Wilson K (1996) The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 23:1407–1417

    PubMed  CAS  Google Scholar 

  64. Hidding A, van Santen M, De Klerk E et al (1994) Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 21:818–823

    PubMed  CAS  Google Scholar 

  65. Martinez-Lavin M (2001) Overlap of fibromyalgia with other medical conditions. Curr Pain Headache Rep 5:347–350

    Article  PubMed  CAS  Google Scholar 

  66. Bennett R (1997) The concurrence of lupus and fibromyalgia: implications for diagnosis and management. Lupus 6:494–499

    PubMed  CAS  Google Scholar 

  67. Alarcon GS (1997) Arthralgias, myalgias, facial erythema, and a positive ANA: not necessarily SLE. Cleve Clin J Med 64:361–364

    PubMed  CAS  Google Scholar 

  68. Martinez-Lavin M, Leon A, Pineda C, Amogo MC, Hermosillo AG (1999) The dysautonomia of fibromyalgia may simulate lupus. J Clin Rheumatol 5:332–334

    Article  PubMed  CAS  Google Scholar 

  69. Gunaydin I, Terhorst T, Eckstein A, Daikeler T, Kanz L, Kotter I (1999) Assessment of keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study. Rheumatol Int 19:7–9

    Article  PubMed  CAS  Google Scholar 

  70. Rhodus NL, Fricton J, Carlson P, Messner R (2003) Oral symptoms associated with fibromyalgia syndrome. J Rheumatol 30:1841–1845

    PubMed  Google Scholar 

  71. Price EJ, Venables PJ (2002) Dry eyes and mouth syndrome–a subgroup of patients presenting with sicca symptoms. Rheumatology (Oxford) 41:416–422

    Article  CAS  Google Scholar 

  72. Barton A, Pal B, Whorwell PJ, Marshall D (1999) Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol 94:1898–1901

    Article  PubMed  CAS  Google Scholar 

  73. Wright M (2002) Widespread body pain and mortality. Diagnosing fibromyalgia stops doctors from thinking. BMJ 324:300

    Article  PubMed  Google Scholar 

  74. Fitzcharles MA, Esdaile JM (1997) The overdiagnosis of fibromyalgia syndrome. Am J Med 103:44–50

    Article  PubMed  CAS  Google Scholar 

  75. Ohtsuka T, Tamura T, Yamakage A, Yamazaki S (1998) The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 38:757–764

    Google Scholar 

  76. Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424–432

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital, Otfried-Mueller-Str. 10, Tübingen, Germany

    Ina Kötter, Daniela Neuscheler, Ilhan Günaydin & Reinhild Klein

  2. Department of Transfusion Medicine, University Hospital, 72076, Tübingen, Germany

    Dorothee Wernet

Authors
  1. Ina Kötter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Neuscheler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilhan Günaydin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dorothee Wernet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Reinhild Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ina Kötter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kötter, I., Neuscheler, D., Günaydin, I. et al. Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up. Rheumatol Int 27, 1031–1039 (2007). https://doi.org/10.1007/s00296-007-0413-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-007-0413-7

Keywords

Search

Navigation